Abiomed shares slump with news of Impella DoJ investigation
This article was originally published in Clinica
Executive Summary
Abiomed is having more problems with its Impella 2.5 heart pump – the US Attorney's Office is investigating the firm's marketing and labelling of the device. The firm said it is "in the process of responding to the subpoena and intends to cooperate fully".